Charter Oak Capital Management LLC Acquires 55 Shares of The Cigna Group (NYSE:CI)

Charter Oak Capital Management LLC raised its holdings in shares of The Cigna Group (NYSE:CI) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 931 shares of the health services provider’s stock after acquiring an additional 55 shares during the quarter. Charter Oak Capital Management LLC’s holdings in The Cigna Group were worth $257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in CI. Susquehanna Fundamental Investments LLC purchased a new position in The Cigna Group during the 2nd quarter valued at about $4,297,000. Algert Global LLC purchased a new stake in The Cigna Group during the second quarter valued at about $523,000. Magnolia Capital Advisors LLC purchased a new position in shares of The Cigna Group during the 2nd quarter valued at about $236,000. NewEdge Advisors LLC boosted its stake in The Cigna Group by 36.5% in the second quarter. NewEdge Advisors LLC now owns 19,522 shares of the health services provider’s stock worth $6,453,000 after buying an additional 5,224 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its position in The Cigna Group by 1.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,675 shares of the health services provider’s stock valued at $6,836,000 after acquiring an additional 272 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on CI. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research note on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Truist Financial lowered their price objective on The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Piper Sandler restated an “overweight” rating and issued a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and an average price target of $395.93.

The Cigna Group Trading Up 4.2 %

NYSE:CI opened at $305.91 on Tuesday. The company has a 50-day moving average price of $297.18 and a 200-day moving average price of $325.56. The stock has a market cap of $85.09 billion, a price-to-earnings ratio of 28.86, a P/E/G ratio of 0.78 and a beta of 0.54. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. During the same period in the previous year, the firm posted $6.77 EPS. The business’s revenue was up 29.8% on a year-over-year basis. Equities analysts predict that The Cigna Group will post 28.5 EPS for the current year.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.